Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review

R. Austin (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom)

Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Session: Severe acute asthma and troublesome wheezing
Session type: Thematic Poster
Number: 960
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Austin (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom). Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review. 960

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adverse childhood experience and asthma onset: a systematic review
Source: Eur Respir Rev 2015; 24: 299-305
Year: 2015



Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis
Source: Eur Respir J, 50 (5) 1701153; 10.1183/13993003.01153-2017
Year: 2017



Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021


Association between COPD exacerbations and acute cardiovascular events: a systematic literature review
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021


Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016


Adverse events and mortality in the INSPIRE study (investigating new standards for prophylaxis in reduction of exacerbations)
Source: Eur Respir J 2007; 30: Suppl. 51, 125s
Year: 2007

Medication adherence and the risk of severe asthma exacerbations: a systematic review
Source: Eur Respir J 2015; 45: 396-407
Year: 2015




Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature
Source: Eur Respir J, 52 (4) 1800703; 10.1183/13993003.00703-2018
Year: 2018



QVA149 does not increase the risk of cardio- and cerebro-vascular events, pneumonia and exacerbation events compared with placebo: A network meta-analysis across multiple safety databases
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013

Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019


Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β2-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009


Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020




Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events
Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016
Year: 2017



Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016

Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


The burden of exacerbations in mild asthma: a systematic review
Source: ERJ Open Res, 6 (3) 00359-2019; 10.1183/23120541.00359-2019
Year: 2020



Premature discontinuation of patients: a potential bias in COPD clinical trials
Source: Eur Respir J 2007; 30: 898-906
Year: 2007



The association between adherence and outcomes in severe asthma: a systematic review
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019


The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021